Safety and Efficacy Study in Infant With SBS

Summary

The objective of this clinical study is to evaluate the efficacy and safety of NTRA-9620 compared with placebo in pediatric subjects (aged 28 weeks postmenstrual age to 52 weeks old) with SBS following surgical resection

Timeline

Start

2017-03-20

Primary completion

2018-03-22

Completion

2018-03-22

Outcome

Outcome not reported

Stopped (Enrollment): “Sponsor decision based on enrollment”

Drugs

Indications